| pubmed-article:795443 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:795443 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:795443 | lifeskim:mentions | umls-concept:C0002962 | lld:lifeskim |
| pubmed-article:795443 | lifeskim:mentions | umls-concept:C0520887 | lld:lifeskim |
| pubmed-article:795443 | lifeskim:mentions | umls-concept:C0301630 | lld:lifeskim |
| pubmed-article:795443 | pubmed:issue | 11 | lld:pubmed |
| pubmed-article:795443 | pubmed:dateCreated | 1977-3-15 | lld:pubmed |
| pubmed-article:795443 | pubmed:abstractText | A double-blind cross-over study was performed on 12 men sith stable angina pectoris in order to determine the effect of antilipolytic treatment on exercise tolerance and exercise-induced electrocardiographic changes. The men were exercised to the onset of anginal pain using a reproducible and standardized ergometric load. A nicotinic acid analogue was used to reduce plasma free fatty acids and free glycerol before and during exercise testing and to eliminate their post-exercise rise. This was associated with significant reduction of exercise-induced ST segment depression (p less than 0-005), though there was no significant difference in the duration of exercise before the oneset of pain. A change in the prportions of lipid and carbohydrate for oxidation by the ischaemic myocardium, making relatively more glucose available, is a likely explanation. | lld:pubmed |
| pubmed-article:795443 | pubmed:language | eng | lld:pubmed |
| pubmed-article:795443 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:795443 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:795443 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:795443 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:795443 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:795443 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:795443 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:795443 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:795443 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:795443 | pubmed:issn | 0007-0769 | lld:pubmed |
| pubmed-article:795443 | pubmed:author | pubmed-author:MillerN ENE | lld:pubmed |
| pubmed-article:795443 | pubmed:author | pubmed-author:OliverM FMF | lld:pubmed |
| pubmed-article:795443 | pubmed:author | pubmed-author:LuxtonM RMR | lld:pubmed |
| pubmed-article:795443 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:795443 | pubmed:volume | 38 | lld:pubmed |
| pubmed-article:795443 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:795443 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:795443 | pubmed:pagination | 1204-8 | lld:pubmed |
| pubmed-article:795443 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
| pubmed-article:795443 | pubmed:meshHeading | pubmed-meshheading:795443-H... | lld:pubmed |
| pubmed-article:795443 | pubmed:meshHeading | pubmed-meshheading:795443-A... | lld:pubmed |
| pubmed-article:795443 | pubmed:meshHeading | pubmed-meshheading:795443-H... | lld:pubmed |
| pubmed-article:795443 | pubmed:meshHeading | pubmed-meshheading:795443-A... | lld:pubmed |
| pubmed-article:795443 | pubmed:meshHeading | pubmed-meshheading:795443-B... | lld:pubmed |
| pubmed-article:795443 | pubmed:meshHeading | pubmed-meshheading:795443-G... | lld:pubmed |
| pubmed-article:795443 | pubmed:meshHeading | pubmed-meshheading:795443-P... | lld:pubmed |
| pubmed-article:795443 | pubmed:meshHeading | pubmed-meshheading:795443-M... | lld:pubmed |
| pubmed-article:795443 | pubmed:meshHeading | pubmed-meshheading:795443-N... | lld:pubmed |
| pubmed-article:795443 | pubmed:meshHeading | pubmed-meshheading:795443-M... | lld:pubmed |
| pubmed-article:795443 | pubmed:meshHeading | pubmed-meshheading:795443-F... | lld:pubmed |
| pubmed-article:795443 | pubmed:meshHeading | pubmed-meshheading:795443-C... | lld:pubmed |
| pubmed-article:795443 | pubmed:meshHeading | pubmed-meshheading:795443-E... | lld:pubmed |
| pubmed-article:795443 | pubmed:meshHeading | pubmed-meshheading:795443-H... | lld:pubmed |
| pubmed-article:795443 | pubmed:year | 1976 | lld:pubmed |
| pubmed-article:795443 | pubmed:articleTitle | Antilipolytic therapy in angina pectoris. Reduction of exercise-induced ST segment depression. | lld:pubmed |
| pubmed-article:795443 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:795443 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:795443 | pubmed:publicationType | Controlled Clinical Trial | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:795443 | lld:pubmed |
